PipelinePharma Logo

ivacaftor Tablets 150 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
WHO
Comments
Under R&D Development
Manufacturer #23052

Founded in 2004, the manufacturer is a recognized CTD dossier owner and manufacturer, prominently known for complying with EU-GMP and WHO-GMP standards. It operates globally, marketing products in over 25 countries. As a GMP manufacturer, it employs over 4,500 staff and boasts extensive production capabilities across multiple state-of-the-art lines, ensuring high standards as both a CTD dossier owner and manufacturer. This setup underscores their capacity as a GMP manufacturer dedicated to quality and safety in pharmaceutical manufacturing.

 

 

 

 

Manufacturer usually replies in 24 days

Ivacaftor Manufacturers

Markets of interest

Ivacaftor is used for the management of Cystic Fibrosis (CF) in adults and children who are at least 4 months old and weigh at least 11 pounds (5 kilograms). The substance is for use only in patients with a specific gene mutation related to cystic fibrosis. Before you take ivacaftor, you may need a medical test to make sure you have this gene mutation. The drug is available for sale in the form of tablets, tablets, film-coated, from manufacturers in various countries including Y. The drug is provided by a wide range of Ivacaftor suppliers from various countries including the Y, Y, and Y. Mostly due to the availability of raw materials for the manufacturing process and low labor costs, the leading Ivacaftor manufacturers and distributors are based in India and Argentina.

Licensing and brand names

In 2012, the medication was approved by the FDA in the United States. Ivacaftor is administered as a monotherapy and also administered in combination with other drugs for the management of Cystic Fibrosis. The medication is presently approved in many countries and is available in both generic and trade name versions. The medication is marketed under the trade names including Kalydeco. One of the most popular branded versions of Ivacaftor is manufactured and supplied by the Indian pharmaceutical company MSN Labs. Other manufacturing companies and distributors from European Union, Bosnia and Herzegovina, Canada, Ukraine, Israel have also successfully adapted to the demands of the global marketplace and produce a variant of the drug with Ivacaftor as an active ingredient.

Target supply price

The wholesale acquisition cost for Kalydeco oral tablet 150 mg is around $24,957 for a supply of 56 tablets. The retail price of the same amount of the substance in Europe reaches 17 EUR. The medication wholesale prices and commercial terms can vary depending on the supplier. The medication wholesale prices and commercial terms can vary depending on the supplier.

Information from manufacturers

We provide a detailed list of the Ivacaftor manufacturers and suppliers that you are looking for. You can also find the dossier status of Ivacaftor and the GMP approvals of the different variants of the medication. The product description of all Ivacaftor suppliers contains essential information about the medication you order including clinical data, stability zones, and a list of countries where Ivacaftor is already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms as well as delivery terms. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified Follicle-stimulating hormone suppliers and distributors enter our online marketplace, offering you a risk-free global B2B pharmaceutical sales platform.